CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia

Overview of attention for article published in Clinical Cancer Research, October 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 130,228 followers.

RT @AACR CD62L as a Therapeutic Target in Chronic Lymphocytic #Leukemia: http://t.co/zEAGbefP8X . #ClinicalCancerResearch

CD62L as a Therapeutic Target in Chronic Lymphocytic #Leukemia: http://t.co/GbMiZ1pxel. #ClinicalCancerResearch

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.